Fibrinolytic Therapy for Heart Attacks May Offer Advantages During COVID-19 Pandemic
For patients experiencing an ST-Elevation Myocardial Infarction (STEMI), the medical term for a heart attack, time is muscle.
“When a clot closes the coronary artery, the heart muscle starts dying, and patients can experience chest pain and other symptoms,” said Mauricio Cohen, M.D., professor of medicine and director of the Cardiac Catheterization Laboratory at the University of Miami Miller School of Medicine. “They need to be treated promptly because the longer you take to treat the patient with a heart attack, the more muscle is dying.”
Read more about the therapy »
Dr. Daniel Mintz, founding scientific director of Diabetes Research Institute, passes away
Scientists, physicians and countless patients mourn the passing of Daniel H. Mintz, M.D., emeritus